Huffington Post: Here’s Why New York Needs To Legalize Medical Marijuana Now

New York is poised to become the 23rd state to legalize the use of marijuana for medical purposes.

The Compassionate Care Act, sponsored by Assemblyman Richard Gottfried (D) and state Sen. Diane Savino (D), was passed in the state Senate Health Committee last month, but it still needs to get out of the finance committee before being brought to the floor for a full vote. It would then move to Gov. Andrew Cuomo’s desk to be signed into law.

Cuomo, however, has sent mixed messages over the bill. Although a vocal opponent of any form of marijuana legalization, the New York Democrat has indicated in the past that he’d consider the Compassionate Care Act, and he recently stated that he supports medical marijuana for the seriously ill.

On Wednesday, Cuomo announced that New York will be the second state to launch medical marijuana trials for children suffering from epilepsy. Those trials, however, are limited to Epidiolex, a drug developed by GW Pharmaceuticals that contains a plant-derived, highly purified form of cannabidiol, or CBD, a non-psychoactive compound found in cannabis. CBD is often used for medicinal purposes, but doesn’t produce the “high” sensation associated with marijuana.

While Epidiolex offers promising possibilities, medical marijuana advocates wereoutraged by the governor’s announcement, saying that limited trials don’t go far enough for patients in the state and that Cuomo needs to come out in strong support of the Compassionate Care Act now.

“We don’t need a limited research program that will only help the lucky few who can get in enrolled,” said Wendy Conte of Orchard Park, New York, whose daughter Anna suffers from a severe seizure disorder.

“Epidiolex may not even work for every kid who has a seizure disorder. We want options. And we want a workable system that creates access for all patients’ needs — not just my daughter but all those living with epilepsy, cancer, MS, HIV/AIDS, and other serious illnesses,” said Conte, according to a Drug Policy Alliance statement. “If Gov. Cuomo wants to help Anna, he would support the Compassionate Care Act.”

A number of studies in recent years have shown the medical potential of cannabis. Purified forms may attack some forms of aggressive cancer. Marijuana use also has been tied to better blood sugar control and may help slow the spread of HIV. One study found that legalization of the plant for medical purposes may even lead to lower suicide rates.

Currently, 22 states and the District of Columbia have legalized marijuana for medical purposes, and at least four other states, including New York, appear poised to legalize medical cannabis next.

A recent Qunnipiac poll found that a full 88 percent of New York voters support medical marijuana legalization in the state.

To that end, drug policy reform group DPA developed a website collecting dozens of moving stories from New Yorkers whose lives would be dramatically improved if the New York state Senate passes the Compassionate Care Act before the end of the legislative session on June 19. Here are just a handful of their stories:



Rochester, New York
Christine Emerson’s 7-year-old daughter Julia suffers from refractory epilepsy. From the age of 4, Julia was having nearly 100 grand mal seizures a month.

“I miss my little girl the way she was before the seizures,” Christine says. “Now, she is so sick and so sad, it’s almost unbearable.”

Recently, Julia’s seizures have diminished thanks in part to a drug called Clobazam. That drug’s side effects, however — mood swings, fatigue, confusion and nausea — make it difficult for Julia to be in school.

Unless New York passes the Compassionate Care Act, Christine and her family may have no other choice but to move.

“Based on my own experience as a pediatric nurse practitioner and what I’ve read and seen, I’m very sure that Julia would benefit from it,” she says. “If Compassionate Care doesn’t pass in 2014 in New York, my family will have to join the other ‘medical marijuana refugees’ in Colorado.”



Syracuse, New York
James Paries was diagnosed with multiple sclerosis at age 17. Now 25, he’s unable to work due to the debilitating pain, fatigue and numbness often associated with MS.

Over the years James has been prescribed several different medications to treat his MS, including Marinol, an FDA-approved drug containing 100 percent synthetic THC. But James found the drug to be too potent, saying it made him feel “doped up.” He says smoking medical cannabis, which often contains far less THC than Marinol, doesn’t have the same negative side effects.

“Medical marijuana helps ease the pain associated with MS and helps with my symptoms,” says James.

James avoids taking too many pain medications because of the side effects they can have on organs like the liver, but he can only use medical marijuana infrequently due to it still being illegal in New York.



Mount Vernon, New York
Five years ago, Lauren Carter was diagnosed with multiple sclerosis. Now 28, Lauren can no longer walk and has lost most of her vision. She had to quit her job as an emergency dispatcher and go on disability.

Although medical marijuana is illegal in New York, Lauren says it’s the drug that best alleviates the symptoms of her illness.

“When I use medical marijuana, my tremors stop, the pain stops,” she says. “I can sleep. I can eat. I can see partially out of both eyes. I don’t suffer from side effects like my many other medications, and most importantly I can cope.”

Since being diagnosed, Lauren has moved back in with her mother, who worries her daughter will get caught with pot.

“If it were legal and bought from a legal dispensary, my mother would allow me to use medical marijuana. She hates watching me suffer, but she is afraid,” says Lauren. “Every day is a battle with my body, and medical marijuana helps me to fight. I shouldn’t have to break the law to get it.”



Buffalo, New York
“It feels like someone is sticking a knife in my back and twisting it,” says Chuck Culhane, 69, as he describes the pain associated with his spinal stenosis, a condition that causes a compression on the spinal cord.

Chuck, who has had the condition for a decade, says he cannot stand or sit for more than a few minutes without intense pain. He’s been prescribed hydrocodone, a prescription narcotic, to ease the pain, but he says that the side effects, which include drowsiness, dizziness and nausea, make it difficult to live a normal life.

Although Chuck has never used medical marijuana, he says he’d like to try it as a treatment for his condition, but he’s afraid to given the current marijuana laws in the state.



Troy, New York
Over the last 20 years, Nancy, a mother of three and a grandmother of four, has survived colon cancer, throat cancer and two bouts of breast cancer.

She underwent multiple rounds of chemotherapy treatment, after which she often suffered from pain, nausea, loss of appetite, vomiting and fatigue. Medical marijuana,says Nancy, would have helped alleviate those symptoms.

“I never thought of using medical marijuana, since it’s not legal, but it could have helped me so much,” she says.

One round of chemotherapy caused Nancy to lose 40 pounds, damaging her kidney in the process.

“If I had had medical marijuana, I wouldn’t be dealing with the nephrologist and urologist now,” she says. “Medical marijuana could have done away with some of the nausea and dry heaving that I experienced when I was undergoing chemotherapy treatment.”



New York, New York
Since 1989, Jim Lister has lived with HIV and struggles daily with fatigue, general restlessness, occasional nausea and severe pain due to accelerated deterioration of the joints in his legs and hands.

Although Jim takes several prescribed and over-the-counter medications, he says that marijuana is the only medicine that diminishes and subdues the symptoms that “dominate” his life.

But with medical marijuana illegal in New York, Jim has to break the law every time he uses the substance that best alleviates his symptoms.

“I am not a criminal,” says Jim. “However, I must watch my back like I am one.”

For more patient testimonials and further information about the Compassionate Care Act, visit DPA’s website.


Supreme Pharmaceuticals Inc. Announces Second Acquisition Target

VANCOUVER, BRITISH COLUMBIA, May 13, 2014 (Marketwired via COMTEX) — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (cse:SL) SPRWF +29.17%is pleased to report that the Company has signed a letter of intent (“LOI”) to acquire a green house facility and 100% of a Southern Ontario based company (the “Target Company”) that has been approved for a pre-build Marijuana for Medical Purposes Regulations license (“MMPR Licence”). Under the terms of the MMPR License, the Target Company can build out and operate a 342,000 square foot facility that can produce up to 24,000,000 grams (24,000 kilograms) of medicinal marijuana per year. Supreme has made an initial $250,000 payment under the terms of the LOI, and must, by May 22nd, 2014 advance to the Target Company an additional $750,000, at which time Supreme will own the Facility, as described below. The transaction terms contained in the LOI are binding on the parties, subject to final documentation. Supreme currently has the necessary funds on hand to close this portion of the transaction.

The Target Company has the option to purchase an Ontario facility that is a state of the art 342,000 square foot facility covering approximately 7 acres that was originally built by Agriculture Canada (“the Facility”). The Target Company has placed in trust with the vendor of the Facility the initial down payment of $250,000 to buy the Facility, and upon Supreme providing the balance of the closing payment of $750,000, the Facility will be fully owned by Supreme. who will have a two-year period to pay to the vendor another $4,500,000. Upon closing of the acquisition of the Facility, year one will be an interest free period, and year two will bear interest of 7%.

To complete the licensing requirement and move from pre-build status to MMPR, the Target Company must complete the installation of the required security measures. Once Health Canada completes its final inspection of the Facility, the Target Company will be granted an MMPR licence. It is anticipated that initial production could commence by the fourth quarter of 2014. The Target Company anticipates it will take 90 days after taking over the Facility to construct and implement the required security measures.

Health Canada has stated that as of 2013 there were 40,000 users of medical marijuana and that by 2024 there could be over 450,000. The industry is evolving rapidly as Supreme looks to become a commercial producer in Canada.

Terms of the Target Company Acquisition

Following the closing of the purchase of the Facility, Supreme has agreed to buy all of the issued and outstanding shares of the Target Company in exchange for that number of shares representing 45% of the current issued and outstanding common shares of Supreme, subject to regulatory approval. Neither control or the board of Supreme shall not change.

Management stated: “This new acquisition is in line with Supreme’s goal of becoming a national company with its potential acquisitions in both British Columbia and Southern Ontario. We believe this transaction could provide significant upside potential for our shareholders. We have made this strategic acquisition to build long-term value for our shareholders.”

Your 5-step primer to investing in pot stocks

Great Article from David Pett of the Financial Post. Reefer madness is back. But this time it’s not high school delinquents going crazy, but equity investors hell bent on marijuana-related stocks. Shares in companies catering to the multi-billion-dollar pot industry have soared this year due to legislative changes south of the border that vastly reduce […]

Continue reading...

Can Tweets And Facebook Posts Predict Stock Behaviour?

Article By Brian O’Connell of on March 18, 2014 On November 11, 2013, a few minutes after 8 a.m. EST, news leaked out from a Canadian newspaper that Blackberry’s $4.7 billion buyout had collapsed. Wall Street wouldn’t find out for a full 180 seconds, when the newswires picked up the report in real time. Investment clients […]

Continue reading...

Canadian Federal Court Judge’s MMPR Injunction Very Positive for Abattis.

News today from the Wall Street Journal: Vancouver, BC / ACCESSWIRE / March 24, 2014 / Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTC PINK: ATTBF) (CSE: ATT), is pleased to comment on Canadian Federal judge Justice Michael D. Manson’s ruling on March 21, 2014. A Federal Court judge issued an injunction Friday that exempts […]

Continue reading...

In-the-know insiders are dumping stocks

By Mark Hulbert, MarketWatch BloombergEnlarge Image Corporate insiders are more bearish than they have been in almost 25 years. That isn’t good news for the stock market, since these insiders — corporate officers and directors— know more about their companies’ prospects than the rest of us. In fact, you may want to take their pessimism as […]

Continue reading...

Canadian penny stock Flyht Aerospace Solutions Ltd soars after disappearance of Malaysian flight

MH370 Malaysia Airlines incident gives black box maker’s stocks bump It is rare for a penny stock in Canada that isn’t a miner to garner much attention, but shares in Flyht Aerospace Solutions Ltd. jumped 25% on Monday on the TSX Venture Exchange before dipping a bit Tuesday. The reason for the gain: The […]

Continue reading...

My new favorite trading tool

Screen Shot 2014-03-10 at 11.59.03 AM

My friends Kyle and Ken of Benzinga are offering up Benzinga Pro for only $1 for your first month.  If you haven’t heard of this service; I recommend you do some DD on it, read the reviews, call them directly… it’s the real deal, and it gets you real-time actionable information and trade alerts BEFORE […]

Continue reading...

Gupta: ‘I am doubling down’ on medical marijuana

Dr. Sanjay Gupta is a practicing neurosurgeon and CNN’s chief medical correspondent. (CNN) – It’s been eight months since I last wrote about medical marijuana, apologizing for having not dug deeply into the beneficial effects of this plant and for writing articles dismissing its potential. I apologized for my own role in previously misleading people, and I […]

Continue reading...

Capitalizing On Cannabis: High Returns Yet Again

Fantastic article on Seeking Alpha today from my good friend, Alan Brochstein, CFA: Includes:FULL, FITX, PHOT, CARA, SPLI, EDXC Editors’ Note: This article covers stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks. Despite concerns of an overheated market after the […]

Continue reading...